Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-26T16:47:39.042Z Has data issue: false hasContentIssue false
  • English
  • Français

The ethics of continuation studies in dementia

Published online by Cambridge University Press:  02 January 2018

John M. Kellett
John M. Kellett*
Affiliation:
St George's Hospital, Blackshaw Road, London SW17 0QT
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

At least one ethical committee is not prepared to approve open continuation studies of treatments for dementia. The author considers that such studies are an ethical necessity if patients are to give six months of their illness to trying out what may be placebo. The reasons for this conflict are discussed. In particular, it is suggested that such studies contribute real scientific information.

Type
Briefings
Information
Psychiatric Bulletin , Volume 20 , Issue 8 , August 1996 , pp. 485
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1996

References

Hirsch, S. & Spence, S. (1995) Ethical approaches to researching the mentally incapable patient. Psychiatric Bulletin, 19, 414–416.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.